Prospective Feasibility Pilot Study Evaluating the Value of [68Ga]Ga-PENTIXAFOR PET-CT in Patients With Metastatic Small Cell Lung Cancer (SCLC) at Diagnosis and Disease Progression

NCT07007325 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

NOT_YET_RECRUITING

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Small Cell Lung Carcinoma (SCLC)

Interventions

DRUG: [68Ga]Ga-PentixaFor

Sponsor

Institut Cancerologie de l'Ouest